Stephen R Ash Selected Research

Acidosis

1/2022

Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen R Ash Research Topics

Disease

5	Liver Failure 04/2022 - 01/2002
3	Drug Overdose 04/2022 - 01/2002
3	Chronic Renal Insufficiency 01/2022 - 08/2015
3	Infections 06/2009 - 03/2006
2	Hyperkalemia 01/2022 - 08/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 04/2011
2	Pathologic Constriction (Stenosis) 01/2013 - 11/2008
2	Hernia (Hernias) 01/2013 - 04/2002
2	Hemorrhage 04/2011 - 05/2009
2	Sepsis (Septicemia) 04/2011 - 01/2002
2	Thrombosis (Thrombus) 04/2011 - 09/2008
2	Catheter-Related Infections 11/2008 - 01/2000
2	Bacteremia 03/2006 - 01/2000
2	Brain Diseases (Brain Disorder) 01/2002 - 01/2002
1	Hepatic Encephalopathy 04/2022
1	Acidosis 01/2022
1	Constipation 08/2015
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 01/2013
1	Shock 01/2013
1	Thrombocytopenia (Thrombopenia) 04/2011
1	Renal Insufficiency (Renal Failure) 11/2009
1	Wounds and Injuries (Trauma) 11/2008
1	Acute-On-Chronic Liver Failure 04/2006
1	Acute Kidney Injury (Acute Renal Failure) 03/2005
1	Peritonitis 04/2002
1	Cardiotoxicity 01/2002
1	Coma (Comas) 01/2002
1	Hepatitis 01/2002
1	Hypotension (Low Blood Pressure) 01/2002
1	Pneumonia (Pneumonitis) 01/2002
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2002
1	Disease Progression 01/2002

Drug/Important Bio-Agent (IBA)

4	Bicarbonates (Hydrogen Carbonate)IBA 01/2022 - 01/2002
4	Heparin (Liquaemin)FDA LinkGeneric 04/2011 - 01/2000
3	Dialysis SolutionsIBA 04/2022 - 04/2006
3	SolutionsIBA 04/2011 - 01/2000
2	PotassiumIBA 01/2022 - 08/2015
2	CationsIBA 08/2015 - 01/2002
2	Methylene Blue (Methylthioninium Chloride)FDA Link 04/2011 - 03/2006
2	SuspensionsIBA 04/2006 - 11/2004
1	CarbonIBA 04/2022
1	AlbuminsIBA 04/2022
1	Biological ProductsIBA 04/2022
1	sodium zirconium cyclosilicateIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	AngiotensinsIBA 08/2015
1	AldosteroneIBA 08/2015
1	ReninIBA 08/2015
1	Phenobarbital (Luminal)FDA Link 04/2011
1	methylparaben FDA LinkGeneric 04/2011
1	propylparaben FDA LinkGeneric 04/2011
1	Sodium Citrate FDA LinkGeneric 04/2011
1	Uremic ToxinsIBA 11/2009
1	ElectrolytesIBA 11/2009
1	AnticoagulantsIBA 05/2009
1	Local Anti-Infective Agents (Antiseptics)IBA 11/2008
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2002
1	Alanine Transaminase (SGPT)IBA 01/2002
1	Bile Acids and Salts (Bile Acids)IBA 01/2002
1	BilirubinIBA 01/2002
1	Charcoal (Charbon)IBA 01/2002
1	Proteins (Proteins, Gene)FDA Link 01/2002
1	Citric Acid (Citrate)FDA LinkGeneric 01/2000
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2000

Therapy/Procedure

8	Catheters 01/2013 - 01/2000
5	Therapeutics 01/2022 - 01/2002
5	Renal Dialysis (Hemodialysis) 01/2013 - 04/2006
3	Central Venous Catheters 01/2013 - 01/2000
2	Peritoneal Dialysis 01/2013 - 03/2005
1	Artificial Liver (Bioartificial Liver) 11/2007
1	Hemoperfusion 01/2002
1	Mechanical Ventilators (Ventilator) 01/2002